Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.0%

1 terminated/withdrawn out of 49 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

0%

0 of 17 completed trials have results

Key Signals

21 recruiting

Enrollment Performance

Analytics

N/A
19(90.5%)
Phase 4
2(9.5%)
21Total
N/A(19)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (49)

Showing 20 of 49 trials
NCT07566624Not Yet Recruiting

Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation

Role: lead

NCT05698732Recruiting

Coroflex® ISAR NEO PMCF Study

Role: lead

NCT06736899Not ApplicableRecruiting

Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions

Role: lead

NCT06214819Not ApplicableActive Not Recruiting

Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.

Role: lead

NCT06863155Recruiting

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

Role: lead

NCT05788432Recruiting

Sequent Extended Study

Role: lead

NCT06321757Recruiting

PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients

Role: lead

NCT07190690Not ApplicableRecruiting

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

Role: lead

NCT07399002Recruiting

LONG NAGOMI™ PMCF STUDY

Role: lead

NCT07256249Recruiting

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

Role: lead

NCT06448637Not ApplicableRecruiting

DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY) IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY)

Role: lead

NCT06273293Not ApplicableRecruiting

Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)

Role: lead

NCT06631157Recruiting

Essential Pro Study ( rEPIC04E-HK )

Role: lead

NCT04899141Active Not Recruiting

Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice

Role: lead

NCT04604197Not ApplicableActive Not Recruiting

ANGiographic Evaluation of Left Main Coronary Artery INtErvention

Role: lead

NCT06272643Active Not Recruiting

Comparison Between Optical Coherence Tomography and Intravascular Ultrasound for Intermediate Left Main Coronary Artery Lesions

Role: lead

NCT06657833Not ApplicableRecruiting

DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

Role: lead

NCT05193019Active Not Recruiting

Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients

Role: lead

NCT07286578Not ApplicableRecruiting

A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

Role: lead

NCT05599061Not ApplicableRecruiting

Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial

Role: lead